Legend Biotech ( (LEGN) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Legend Biotech’s stock surged due to takeover rumors highlighted in Betaville blog, despite RBC Capital lowering its price target from $86 to $84 following adjustments in sales estimates for Carvykti. Additionally, the company announced an employee transition agreement and plans to meet with Piper Sandler, potentially affecting future investor sentiment.
More about Legend Biotech
YTD Price Performance: -5.64%
Average Trading Volume: 1,496,274
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $6.01B
For further insights into LEGN stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.